相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer
Hirotsugu Kenmotsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study
Wenyu Zhai et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Efficacy of Platinum-Based Adjuvant Chemotherapy on Prognosis of Pathological Stage II/III Lung Adenocarcinoma based on EGFR Mutation Status: A Propensity Score Matching Analysis
Tetsuya Isaka et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Prognostic value of the frequency of vascular invasion in stage I non-small cell lung cancer
Satoshi Okada et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2017)
Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study
Chenyang Dai et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma
Naoki Yanagawa et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC
Daniel Morgensztern et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis
Bing Hou et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2016)
Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer
Yasuhiro Tsutani et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
Visceral Pleural Invasion Does Not Affect Recurrence or Overall Survival Among Patients With Lung Adenocarcinoma ≤ 2 cm A Proposal to Reclassify T1 Lung Adenocarcinoma
Jun-ichi Nitadori et al.
CHEST (2013)
Treatment of Stage I and II Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John A. Howington et al.
CHEST (2013)
Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non-Small-Cell Lung Cancer
Hai-bo Sun et al.
CLINICAL LUNG CANCER (2013)
Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer
Seong Yong Park et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2013)
Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer
Michael F. Nentwich et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
L. Crino et al.
ANNALS OF ONCOLOGY (2010)
Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer Results of an Exploratory Subgroup Analysis of a Phase III Trial
Chih-Hsin Yang et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Local Recurrence After Surgery for Early Stage Lung Cancer An 11-Year Experience With 975 Patients
Chris R. Kelsey et al.
CANCER (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence
J-J Hung et al.
THORAX (2009)
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Gary M. Strauss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Identification of a low risk subgroup of stage IB lung adenocarcinoma patients
Tetsuya Mizuno et al.
LUNG CANCER (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
T Winton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Postoperative adjuvant chemotherapy for stage I non-smatt cell lung cancer
JH Park et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2005)
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
T Le Chevalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
R Sordella et al.
SCIENCE (2004)
分享论文
